Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
- PMID: 36868923
- PMCID: PMC10173173
- DOI: 10.1016/j.abd.2022.09.005
Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
Abstract
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusively cutaneous disease or be one of the multiple manifestations of systemic lupus erythematosus. Its classification includes acute, subacute, intermittent, chronic and bullous subtypes, which are usually identified based on clinical features and histopathological and laboratory findings. Other non-specific cutaneous manifestations may be associated with systemic lupus erythematosus and are usually related to disease activity. Environmental, genetic and immunological factors play a role in the pathogenesis of skin lesions in lupus erythematosus. Recently, considerable progress has been made in elucidating the mechanisms involved in their development, which allows for foreseeing future targets for more effective treatments. This review proposes to discuss the main etiopathogenic, clinical, diagnostic and therapeutic aspects of cutaneous lupus erythematosus, aiming to update internists and specialists from different areas.
Keywords: Autoimmune diseases; Lupus erythematosus, cutaneous; Lupus erythematosus, discoid; Lupus erythematosus, systemic; Panniculitis, lupus erythematosus.
Copyright © 2023 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. All rights reserved.
Figures





Similar articles
-
Cutaneous lupus erythematosus: a review.Dermatol Clin. 2002 Jul;20(3):373-85, v. doi: 10.1016/s0733-8635(02)00016-5. Dermatol Clin. 2002. PMID: 12170873 Review.
-
[Skin manifestations of lupus erythematosus].Ther Umsch. 2005 May;62(5):303-12. doi: 10.1024/0040-5930.62.5.303. Ther Umsch. 2005. PMID: 15945221 Review. German.
-
Lupus erythematosus: Management of cutaneous manifestations during pregnancy.Dermatol Ther. 2022 Jun;35(6):e15486. doi: 10.1111/dth.15486. Epub 2022 Apr 29. Dermatol Ther. 2022. PMID: 35373415 Review.
-
Cutaneous manifestations of lupus erythematosus.Rheum Dis Clin North Am. 1994 Feb;20(1):195-212. Rheum Dis Clin North Am. 1994. PMID: 8153399 Review.
-
The classification and diagnosis of cutaneous lupus erythematosus.J Autoimmun. 2014 Feb-Mar;48-49:14-9. doi: 10.1016/j.jaut.2014.01.021. Epub 2014 Jan 31. J Autoimmun. 2014. PMID: 24486120 Review.
Cited by
-
Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus.Medicina (Kaunas). 2023 Nov 17;59(11):2022. doi: 10.3390/medicina59112022. Medicina (Kaunas). 2023. PMID: 38004071 Free PMC article.
-
Cutaneous Manifestations of Systemic Lupus Erythematosus and Their Correlation With Cardiac Involvement.Cureus. 2024 Dec 27;16(12):e76478. doi: 10.7759/cureus.76478. eCollection 2024 Dec. Cureus. 2024. PMID: 39866976 Free PMC article. Review.
-
The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review.J Clin Med. 2024 Apr 21;13(8):2419. doi: 10.3390/jcm13082419. J Clin Med. 2024. PMID: 38673692 Free PMC article. Review.
-
Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy.Front Immunol. 2025 Mar 28;16:1539373. doi: 10.3389/fimmu.2025.1539373. eCollection 2025. Front Immunol. 2025. PMID: 40226630 Free PMC article.
-
Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries.Int J Mol Sci. 2024 Jul 16;25(14):7762. doi: 10.3390/ijms25147762. Int J Mol Sci. 2024. PMID: 39063004 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical